Analysis on genomic Instability with aging in rats developed spontaneous hepaticis hepatoma Senior Research Scientist
自发性肝癌大鼠基因组随衰老的不稳定性分析 高级研究科学家
基本信息
- 批准号:08838027
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The LEC (Long-Evans Cinnamon) mutant strain of rat accumulates copper in the liver due to a mutation in the Atp7b gene, which encodeds a copper-ATPase. It spontaneously develops hepatitis, and subsequently hepatocellular carcinomas and cholangiofibrosis. Excess intracellular copper has been thought to induce DNA damage throughout reactive oxygen species (ROS) produced by Cu (II) /Cu (I) redox cycling and also by direct interaction with DNA.We developed 1acl transgenic LEC rats, by mating LEC and Big Blue F344 rats carrying a lambda shuttle vector harbo6ng the lacI and utilized them to examine rates of somatic mutation in vivo. At 24 weeks of age, the livers of four Big Blue F344 rats and of eight lacI transgenic LEC rats were analyzed for the mutant frequency of lacI using the color screening technique. The mutant frequencies (mean+-SD) in the lacI transgenic LEC rats was 12.8+-8.3 x 10-5,25-fold higher than that in Big Blue case. The level of copper accumulation in the livers of lacI transgenic LEC rats was 265+-72 micro g/g, 53-fold the amount in Big Blue F344 rats. Plasma levels of glutamic oxaloacetic transaminase and glutamic pyruvic transaminase, assayd as markers of hepatitis development, were also much higher in lacI transgenic LEC rats. We hypothesize that the remarkable increase in mutant frequency in the LEC rat liver may play a crucial role in its hepatocarcinogenesis.
LEC(Long-Evans Cinnamon)突变型大鼠品系由于Atp 7 b基因突变而在肝脏中积累铜,Atp 7 b基因编码铜ATP酶。它自发地发展为肝炎,随后发展为肝细胞癌和胆管纤维化。本研究通过将携带lacI的λ穿梭载体的LEC和Big Blue F344大鼠交配,建立了1acI转基因LEC大鼠,并利用它们在体内检测了体细胞突变率。在24周龄时,使用颜色筛选技术分析了4只Big Blue F344大鼠和8只lacI转基因LEC大鼠的肝脏的lacI突变频率。lacI转基因LEC大鼠的突变频率(平均值± SD)为12.8 ± 8.3 × 10 ~(-5),比大蓝鼠高25倍。lacI转基因LEC大鼠肝脏中的铜积累水平为265 ± 72微克/克,是Big Blue F344大鼠的53倍。在lacI转基因LEC大鼠中,作为肝炎发展标志物的谷草转氨酶和谷丙转氨酶的血浆水平也要高得多。我们推测LEC大鼠肝脏突变频率的显著增加可能在其肝癌发生中起着至关重要的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SONE Hideko其他文献
Integrative Approaches of Bioassay and Computational Analysis for Discovering Potential Bioactive Compounds and Predictive Toxicity
用于发现潜在生物活性化合物和预测毒性的生物测定和计算分析的综合方法
- DOI:
10.3177/jnsv.68.s131 - 发表时间:
2022 - 期刊:
- 影响因子:1.6
- 作者:
SONE Hideko;QIN Xian-Yang;HAYAMIZU Kohsuke;FUJIBUCHI Wataru;NAKAO Yoichi - 通讯作者:
NAKAO Yoichi
SONE Hideko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SONE Hideko', 18)}}的其他基金
Development study of the prediction system using mouse ES cells to detect next generation influences
利用小鼠ES细胞检测下一代影响的预测系统的开发研究
- 批准号:
18310025 - 财政年份:2006
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
美国的全氟烷基物质 (PFAS) 和肝癌风险
- 批准号:
10365240 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Working to Eliminate Care Disparities in Liver Cancer in Southeast Asian Americans: Transportation and Other Social Determinants of Health.
努力消除东南亚裔美国人肝癌护理差异:交通和其他健康的社会决定因素。
- 批准号:
10710050 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Working to Eliminate Care Disparities in Liver Cancer in Southeast Asian Americans: Transportation and Other Social Determinants of Health.
努力消除东南亚裔美国人肝癌护理差异:交通和其他健康的社会决定因素。
- 批准号:
10584157 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
A Role for the Novel HAF-NFkappaB Axis in Driving Obesity-Associated Liver Cancer
新型 HAF-NFkappaB 轴在驱动肥胖相关肝癌中的作用
- 批准号:
10446842 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Immune profiling to detect viral hepatitis-related liver cancer in HIV-infected patients
免疫分析检测 HIV 感染者中病毒性肝炎相关肝癌
- 批准号:
10703227 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
A Role for the Novel HAF-NFkappaB Axis in Driving Obesity-Associated Liver Cancer
新型 HAF-NFkappaB 轴在驱动肥胖相关肝癌中的作用
- 批准号:
10676965 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
美国的全氟烷基物质 (PFAS) 和肝癌风险
- 批准号:
10652966 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Immune profiling to detect viral hepatitis-related liver cancer in HIV-infected patients
免疫分析检测 HIV 感染者中病毒性肝炎相关肝癌
- 批准号:
10536532 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer
重新设计的线粒体靶向 p53 基因疗法治疗肝癌
- 批准号:
10317129 - 财政年份:2021
- 资助金额:
$ 1.41万 - 项目类别:
Liver Cancer Disparities in Alaska Native and American Indian People
阿拉斯加原住民和美洲印第安人的肝癌差异
- 批准号:
10286757 - 财政年份:2021
- 资助金额:
$ 1.41万 - 项目类别: